Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
allergan
3
×
biotech
boston blog main
boston top stories
clinical trials
eli lilly
fda
life sciences
3
×
national blog main
national top stories
abbvie
amgen
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
marc goodman
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
svb leerink
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
10x genomics
alder biopharmaceutical
alkermes
american academy of neurology
anemia
What
fda
won
3
×
drug
drugs
alkermes
antipsychotic
approval
arguments
august
benefits
big
bio
biotech
busy
caveats
class
commercialized
commonly
companies
competitors
days
decades
decisions
designed
devices
effect
favor
gain
legacy
make
medicine
meeting
migraine
neuro
new
news
nods
offer
opioid
oral
Language
unset
Current search:
won
×
allergan
×
" life sciences "
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments